Stay updated on Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial
Sign up to get notified when there's something new on the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page.

Latest updates to the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA general NIH website-transition notice appears above the ClinicalTrials.gov page, which continues to show a 403 error instead of the study record. The footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied message. This reflects that the study information is no longer accessible on the page, rather than updates to the study details themselves.SummaryDifference19%

- Check47 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0, indicating a site version update rather than a change to the study details.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page revision metadata was updated from v3.6.5 to v3.6.6, indicating a minor version update to the page. There is no indication of changes to the study content or details.SummaryDifference0.0%

- Check68 days agoChange DetectedA funding note for 2016 indicating an NIH grant/contract was added near the study identifiers, signaling source of support for the trial.SummaryDifference0.0%

Stay in the know with updates to Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page.